News
Johnson & Johnson, Pharma and Beating Profit
Digest more
The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.
This week's dividend activity included increased payouts from Citigroup (NYSE:C) and Duke Energy (DUK) as well as ...
Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...
Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...
The healthcare industry offers many attractive dividend investments. Both Johnson & Johnson as well as Pfizer have a positive outlook.
The CDC has approved eligibility guidelines for the Pfizer vaccine booster. Recommendations for Moderna and Johnson & Johnson could come soon.
Comparing the COVID-19 vaccines: If you have a choice, which one should you get? Pfizer, Moderna and Johnson & Johnson are all safe and effective, but there are some differences.
Health experts say not to hold out for a certain vaccine. But Pfizer, Moderna and Johnson & Johnson doses are available in Illinois. Can you choose?
CDC recommends Pfizer, Moderna vaccines over Johnson & Johnson, citing rare blood-clot issue Nine deaths, several dozen cases, have been confirmed in connection with the vaccine.
According to medical experts, the Johnson & Johnson, Pfizer and Moderna COVID vaccines each offer some level of protection, but how do they compare to each ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback